Market News AIOpen the app

Lisata Therapeutics, Inc. has signed a big deal to merge with Marea Therapeutics.

DealRead the original at sec.gov
Bad for LSTA

Lisata acquired Marea and issued stock that leaves pre-transaction Lisata holders with about 3.9% ownership before financing, greatly reducing existing shareholders' ownership and control.

LSTA · Lisata Therapeutics, Inc.

AI read · Bad for LSTA

The AI's read

The merger hands control and most shares to former Marea holders and new investors, leaving existing Lisata holders with a very small ownership stake. That change shrinks current shareholders' voting power and increases the chance of governance and listing changes.

Get alerts for LSTA

Follow Lisata Therapeutics, Inc. (LSTA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LSTA
Free on the App Store and Google Play, or on the web.